Skip Navigation

News Center

Journalists & Bloggers

LIXTE Biotechnology (LIXT) Bringing First-in-Class Approach to Chemo and Immunotherapy

Feb. 12, 2026 3:00 PM ET Source: Investor Brand Network

Investor Brand Network

More Company News

Soligenix (SNGX) Leverages Platform Science for Broader Therapeutic Reach

HeartBeam (BEAT) Enrolls First Patients in ALIGN-ACS Pilot Study for Heart Attack Detection

HeartBeam (BEAT) Announces Commercial Partnership With ClearCardio

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

NewMediaWire Home
For Journalists & Bloggers
Follow on X - opens in new tab

Terms of Use Privacy Policy Contact Us

© 2026 NewMediaWire

Upload Release

Home
Distributions
Investor Relations
- Investor Relations Suite
- SEC Financial Filings & Regulatory Compliance
Media Targeting
News Center

Follow Us